BRPI0807065A2 - biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos - Google Patents

biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos

Info

Publication number
BRPI0807065A2
BRPI0807065A2 BRPI0807065A BRPI0807065A BRPI0807065A2 BR PI0807065 A2 BRPI0807065 A2 BR PI0807065A2 BR PI0807065 A BRPI0807065 A BR PI0807065A BR PI0807065 A BRPI0807065 A BR PI0807065A BR PI0807065 A2 BRPI0807065 A2 BR PI0807065A2
Authority
BR
Brazil
Prior art keywords
making
drug release
new biomaterials
eye drug
eye
Prior art date
Application number
BRPI0807065A
Other languages
English (en)
Inventor
R Haberer Barbara
N Chang James
L Kloster Kaia
D Youso Patrick
E Utecht Ronald
M Downey Therese
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0807065A2 publication Critical patent/BRPI0807065A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
BRPI0807065A 2007-01-31 2008-01-31 biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos BRPI0807065A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88755907P 2007-01-31 2007-01-31
PCT/US2008/001301 WO2008094659A2 (en) 2007-01-31 2008-01-31 Novel biomaterials for ocular drug delivery and a method for making and using same

Publications (1)

Publication Number Publication Date
BRPI0807065A2 true BRPI0807065A2 (pt) 2017-03-21

Family

ID=39409833

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807065A BRPI0807065A2 (pt) 2007-01-31 2008-01-31 biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos

Country Status (9)

Country Link
US (5) US9855337B2 (pt)
EP (2) EP2425816A3 (pt)
JP (2) JP5541926B2 (pt)
KR (1) KR20090108723A (pt)
AU (1) AU2008211083B2 (pt)
BR (1) BRPI0807065A2 (pt)
CA (1) CA2676919C (pt)
MX (1) MX2009008170A (pt)
WO (2) WO2008094659A2 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007142704A2 (en) 2006-06-02 2007-12-13 Hawaii Chitopure, Inc. Chitosan-derivative compounds and methods of controlling microbial populations
US20080248508A1 (en) * 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
US9855337B2 (en) * 2007-01-31 2018-01-02 Alumend, Llc Biomaterials and a method for making and using the same
NZ599605A (en) 2007-02-19 2013-11-29 Marinepolymer Tech Inc Hemostatic compositions and therapeutic regimens
US20100009009A1 (en) * 2008-07-10 2010-01-14 Micropure, Inc. Method and composition for prevention and treatment of oral fungal infections
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
US20100233101A1 (en) 2009-02-13 2010-09-16 Micropure, Inc. Composition and method for the oxidative consumption of salivary biomolecules
WO2011035020A1 (en) 2009-09-18 2011-03-24 Bioinspire Technologies, Inc. Free-standing biodegradable patch
US9271925B2 (en) 2013-03-11 2016-03-01 Bioinspire Technologies, Inc. Multi-layer biodegradable device having adjustable drug release profile
CN101695583B (zh) * 2009-10-29 2012-12-26 中国人民解放军第三军医大学第一附属医院 一种用于组织修复的颗粒状生物材料及其制备方法
AU2011239466B2 (en) 2010-04-15 2015-01-22 Marine Polymer Technologies, Inc. Anti-bacterial applications of poly -N-acetylglucosamine nanofibers
CN103282024A (zh) * 2010-11-06 2013-09-04 海洋聚合物技术公司 用于纳米聚合物基核酸递送的组合物和方法
KR101935068B1 (ko) * 2011-02-14 2019-01-03 알러간, 인코포레이티드 비마토프로스트 조성물의 에스테르 유도체 및 방법
NZ732118A (en) 2011-04-15 2018-11-30 Marine Polymer Tech Inc Treatment of disease with poly-n-acetylglucosamine nanofibers
US9962401B2 (en) * 2011-09-27 2018-05-08 Purdue Research Foundation Chitosan derivatives for inactivation of endotoxins and surface protection of nanoparticles
SG11201400815TA (en) * 2011-10-12 2014-09-26 Ascendis Pharma Ophthalmology Division As Prevention and treatment of ocular conditions
US8968790B2 (en) * 2011-12-09 2015-03-03 Shaker A. Mousa Nanoformulation of vitamin D derivatives and/or vitamin D metabolites
US9956291B2 (en) * 2012-07-10 2018-05-01 Shaker A. Mousa Nanoformulation and methods of use of thyroid receptor beta1 agonists for liver targeting
EP2928501B1 (en) 2012-12-07 2020-05-06 Ascendis Pharma A/S Carrier-linked prostanoid prodrugs
TWI485189B (zh) 2012-12-28 2015-05-21 Ind Tech Res Inst 固體製劑及其製造方法
EP3003026B1 (en) 2013-03-14 2019-07-17 Tricol Biomedical, Inc. Biocompatible and bioabsorbable derivatized chitosan compositions
GB201309788D0 (en) * 2013-05-31 2013-07-17 Medtrade Products Ltd Process for the removal of contamination from a raw material
HUE046425T2 (hu) 2014-05-07 2020-02-28 Croma Pharma Ges M B H Vizes szemészeti oldat és eljárás száraz szem szindróma kezelésére
US10449272B2 (en) 2015-10-16 2019-10-22 Industrial Technology Research Institute Hydrogel composition and method for using the same
MX2018004779A (es) 2015-10-30 2018-06-19 Croma Pharma Ges M B H Uso terapeutico de una solucion oftalmica acuosa esteril.
KR20180066240A (ko) 2015-10-30 2018-06-18 크로마-파르마 게젤샤프트 엠.베.하. 무균 수성 안과용 액제의 치료적 용도
KR102380636B1 (ko) * 2015-12-28 2022-03-31 알루멘드, 엘엘씨 피부 자극에 영향을 미치는 조성물 및 방법
US9867810B1 (en) 2016-08-19 2018-01-16 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
CA3020197A1 (en) 2017-09-01 2019-03-01 Micropure, Inc. Aliphatic anionic compounds and oxidative compounds with improved stability and efficacy for use in pharmaceutical compositions
CN110343263A (zh) * 2018-04-02 2019-10-18 中国海洋大学 一种基于氢氧化钾和低温溶解壳聚糖的方法
US11344507B2 (en) 2019-01-08 2022-05-31 Alumend, Llc Topical compositions containing low molecular weight chitosan derivatives
KR102119693B1 (ko) * 2019-10-31 2020-06-05 경희대학교 산학협력단 숙신화 콜라겐-피브리노겐 하이드로겔의 제조방법
CN115697265A (zh) * 2020-04-03 2023-02-03 组织技术公司 使用脐带产物治疗眼部表面病症的方法
CN113440643B (zh) * 2021-06-10 2022-04-29 武汉大学 一种可吸收外科材料的表面抗菌处理方法
CN113881070B (zh) * 2021-11-09 2022-11-15 中北大学 具有光-应力双重响应的碳量子点/壳聚糖衍生物水凝胶的制备方法及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0540670T3 (da) * 1990-07-26 1996-04-29 Monsanto Co Fremgangsmåde til fremstilling af tværbundne polyaminer
FR2707878A1 (fr) 1993-07-21 1995-01-27 Imedex Nouvelles compositions adhésives à usage chirurgical.
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US5510102A (en) 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
US6015474A (en) 1997-06-20 2000-01-18 Protein Polymer Technologies Methods of using primer molecules for enhancing the mechanical performance of tissue adhesives and sealants
US6200595B1 (en) 1998-04-24 2001-03-13 Kuraray Co., Ltd. Medical adhesive
JP2000288079A (ja) 1999-04-07 2000-10-17 Toyobo Co Ltd 生体組織用接着剤
JP2003503367A (ja) * 1999-06-11 2003-01-28 シアウォーター・コーポレイション キトサンとポリ（エチレングリコール）または関連ポリマーから得られるヒドロゲル
US6310188B1 (en) 2000-01-24 2001-10-30 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for producing chitin or chitosan
US6991652B2 (en) 2000-06-13 2006-01-31 Burg Karen J L Tissue engineering composite
US20040047892A1 (en) * 2000-11-15 2004-03-11 Desrosiers Eric Andre Filler composition for soft tissue augmentation and reconstructive surgery
US6756363B1 (en) * 2000-11-17 2004-06-29 Wound Healing Of Oklahoma, Inc. Solutions and films of glycated chitosan
KR100507968B1 (ko) * 2001-08-18 2005-08-17 한국과학기술연구원 자기집합체를 형성하는 항암제-키토산 복합체 및 그의제조방법
ATA13842001A (de) * 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
ATE506079T1 (de) 2003-11-05 2011-05-15 Photobiomed Corp Verbindungsgewebe und vernetzungsproteine mit naphthalimid-verbindungen
ES2609105T3 (es) * 2004-05-20 2017-04-18 Mentor Worldwide Llc Método de enlance covalente de ácido hialurónico y quitosano
US20050283004A1 (en) * 2004-06-18 2005-12-22 Hopax Chemicals Manufacturing Co., Ltd. Alkylsulfonated polyaminosaccharides
KR100578382B1 (ko) * 2004-07-16 2006-05-11 나재운 항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법
AU2005304034B2 (en) * 2004-11-09 2012-02-16 Santen Sas Ophthalmic emulsions containing an immunosuppressive agent
GB0615834D0 (en) * 2006-08-09 2006-09-20 Univ Glasgow Polymeric micellar clusters and their uses in formulating drugs
US9855337B2 (en) 2007-01-31 2018-01-02 Alumend, Llc Biomaterials and a method for making and using the same

Also Published As

Publication number Publication date
AU2008211083A1 (en) 2008-08-07
KR20090108723A (ko) 2009-10-16
US8252771B2 (en) 2012-08-28
MX2009008170A (es) 2009-08-12
US20160175449A1 (en) 2016-06-23
US20180344858A1 (en) 2018-12-06
EP2114370A2 (en) 2009-11-11
CA2676919C (en) 2013-01-29
US20080200948A1 (en) 2008-08-21
EP2425816A3 (en) 2014-04-30
US20180344859A1 (en) 2018-12-06
US9884121B2 (en) 2018-02-06
EP2114370B1 (en) 2012-10-03
AU2008211083B2 (en) 2013-08-01
US9855337B2 (en) 2018-01-02
WO2008094659A2 (en) 2008-08-07
WO2008094659A3 (en) 2009-05-14
US20080207561A1 (en) 2008-08-28
WO2008094675A3 (en) 2009-11-26
JP2010516814A (ja) 2010-05-20
JP5541926B2 (ja) 2014-07-09
JP2014129408A (ja) 2014-07-10
EP2425816A2 (en) 2012-03-07
CA2676919A1 (en) 2008-08-07
WO2008094675A2 (en) 2008-08-07

Similar Documents

Publication Publication Date Title
BRPI0807065A2 (pt) biomateriais novos para liberação de fármaco ocular e um método para fazer e usar os mesmos
BRPI0921396A2 (pt) dispositivos hápticos para lente intra-ocular
BRPI0815719A2 (pt) métodos para a formação de percursores de lentes oftálmicas e de lentes oftálmicas
BRPI0814383A2 (pt) dispositivo para inserir uma lente intraocular em um olho, e, método de liberação de uma lente intraocular em um olho
BRPI0920137A2 (pt) implante ocular
BRPI0920138A2 (pt) lente intraocular, e, métodos para fabricar uma lente intraocular, e para inserir uma lente intraocular em um paciente
BRPI0821543A2 (pt) Lente intraocular, e, lente oftálmica difrativa
BRPI0913988A2 (pt) conjunto e processo para prover um stent de implante
BRPI0911293A2 (pt) método para formação de uma lente oftálmica compreendendo um material condutor
BRPI1009844A2 (pt) método para produzir uma lente oftálmica tendo um revestimento resistente a risco, revestimento resistente a risco para uma lente oftálmica, e, lente oftálmica
BR112012004459A2 (pt) "liberação pulsátil de medicamentos a partir de um plugue de ponto lacrimal"
BRPI0923477A2 (pt) método e equipamento para limitar o aumento do comprimento ocular
BRPI0912910A2 (pt) molécula bifotocromática, lente oftálmica, material hospedeiro polimérico e método para manufaturar uma molécula bifotocromática
BRPI0921789A2 (pt) Composto de benzotriazol, material para dispostivo oftálmico, lente intraocular e dispositivo oftálmico
BRPI0821174A2 (pt) Unidade de laser para realizar cirurgia a laser oftálmica intraestromal
BRPI0721395A2 (pt) Lente intra-ocular
BRPI0716443A2 (pt) fibra, mÉtodo para fabricar uma fibra, e, produto de fibra
BRPI0717529A2 (pt) Radiocirurgia ocular
BRPI0810370A2 (pt) Stent revestido, e, método para preparar um stent
BR112012001542A2 (pt) lente de contato, e, método para fabricar uma lente de contato
BRPI0921698A2 (pt) metodo e aparelho para formar uma lente oftalmica com uma microcontroladora integrada
BRPI0918851A2 (pt) extrato de tecido adiposo livre de célula, implante, e, métodos para preparar um extrato de tecido adiposo livre de célula, para preparar um implante, e , para induzir adipogênese
BRPI0811927A2 (pt) Lentes oftálmicas para a prevenção da progressão de miopia
EP2134242A4 (en) RING FOR USE IN A PROCESS FOR PHAKOEMULSIFICATION OF TIGHT PUPILS
BRPI0814703A2 (pt) Aparelho e processo para a determinação da correção necessária da visão defeituosa de um olho

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 47/36 (2006.01), A61K 9/00 (2006.01), A61K 31